Receptor Tyrosine Protein Kinase Erbb 4 Market Share, Size, Definition, Causes, Syndrome, Pipeline Review, H1 2016

Receptor Tyrosine Protein Kinase ERBB 4 Market Share, Size,
Definition, Pipeline Review, H1 2016 by Radiant Insights
Summary
Global Markets Direct's, 'Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor
HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review,
H1 2016', provides in depth analysis on Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface
Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) targeted
pipeline therapeutics.
The report provides comprehensive information on the Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase
Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC
2.7.10.1), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological
action of the therapeutics, its complete research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved in Receptor Tyrosine Protein Kinase ERBB 4
(Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4
or ERBB4 or EC 2.7.10.1) targeted therapeutics development and features dormant and discontinued projects.
Browse Complete Summary Click Here @ http://www.radiantinsights.com/research/receptor-tyrosine-proteinkinase-erbb-4
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from...